Synapse - Virginia Klimek

Results (147)

CD99 is a diagnostic and therapeutic target on disease stem cells in MDS and AML

Meeting Abstract

Chung, S. S.; Pang, W. W.; Devlin, S.; Klimek, V. M.; Melnick, A.; Park, C. Y.
Laboratory Investigation (2014)

A phase II study of mocetinostat, an oral isotype-selective histone deacetylase (HDAC) inhibitor, in combination with 5-azacitidine in patients with myelodysplastic syndrome (MDS)

Meeting Abstract

Luger, S. M.; O'Connell, C. L.; Klimek, V.; Cooper, M. A.; Besa, E. C.; Rossetti, J. M.; Reid, G. K.; Humphrey, R.; Martell, R. E.; Garcia-Manero, G.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Comprehensive mutational profiling in myelodysplastic syndromes treated with decitabine and tretinoin

Meeting Abstract

Shih, A. H.; Devlin, S. M.; Dolezal, E. K.; Knapp, K. M.; Wang, K.; Sanford, E. M.; Brennan, T.; Yelensky, R.; Nahas, M.; Otto, G. A.; more...
Blood (2013)

Fulltext@MSK | Save

Combination therapy with mocetinostat, an oral, spectrum-selective histone deacetylase (HDAC) inhibitor, and 5-azaciditine: Indication of clinical activity in MDS

Meeting Abstract

Garcia Manero, G.; Selina, L.; Virginia, K.; Maureen, C.; Besa, E. C.; Rossetti, J. M.; Chao, R.; Humphrey, R.; Silverman, L. R.
Blood (2013)

Fulltext@MSK | Save

High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy

Meeting Abstract

Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
Blood (2013)

Fulltext@MSK | Save

PARP1 is required for chromosomal translocations

Journal Article

Wray, J.; Williamson, E. A.; Singh, S. B.; Wu, Y.; Cogle, C. R.; Weinstock, D. M.; Zhang, Y.; Lee, S. H.; Zhou, D.; Shao, L.; more...
Blood (2013)

Fulltext@MSK | Save

Cd99 identifies disease stem cells in acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS)

Meeting Abstract

Chung, S.; Pang, W.; Jan, M.; Klimek, V.; Weissman, I.; Majeti, R.; Park, C.
Experimental Hematology (2013)

Fulltext@MSK | Save

Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

Journal Article

Shih, A. H.; Chung, S. S.; Dolezal, E. K.; Zhang, S. J.; Abdel-Wahab, O. I.; Park, C. Y.; Nimer, S. D.; Levine, R. L.; Klimek, V. M.
Haematologica (2013)

Fulltext@MSK | Save

Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia

Journal Article

Baljevic, M.; Abdel-Wahab, O.; Rampal, R.; Maslak, P. G.; Klimek, V. M.; Rosenblat, T. L.; Douer, D.; Levine, R. L.; Tallman, M. S.
Acta Haematologica (2013)

Fulltext@MSK | Save

Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia

Journal Article

Klimek, V. M.
Current Opinion in Hematology (2013)

Fulltext@MSK | Save